Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells. - Wikidata - awgldk - TriplyDB

Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.

Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.

http://www.wikidata.org/entity/Q35860804

about

G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC).Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing.Activation of tachykinin, neurokinin 3 receptors affects chromatin structure and gene expression by means of histone acetylation Galanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancer Epigenomic analysis of lung adenocarcinoma reveals novel DNA methylation patterns associated with smoking.Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer.Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma Characterization of the Rat GAL2R Promoter: Positive Role of ETS-1 in Regulation of the Rat GAL2R Gene in PC12 Cells.Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.Galanin receptor 3--a potential target for acute pancreatitis therapy.Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells.Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis.Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember.

P2860

Q26801162-28F7B7BA-8CAE-4C5D-939E-EC19A2E4D06F Q33623170-4259A64C-D474-4700-A2AA-3326619F6F9C Q35052832-64A9AFE4-5301-4878-B32C-AD3999104C64 Q35053490-80442BE0-59E3-44BB-AF7C-E6EF984953E4 Q36442907-01FA83BC-1D5B-44F0-9518-114C1B5D5FEA Q36865069-173D407B-C0F4-4A05-A312-0B80ED2AF4F5 Q37281397-2B8AC653-E628-4BE0-8494-6591126BDD41 Q37690752-F81500BA-FC28-4395-8D4A-B220F701B42A Q39069156-7C87490F-ECD0-42C3-9E90-365D75BAD282 Q39079661-122283FE-6041-42E4-8DED-722D26108040 Q39192279-3F694150-3518-4763-BAD6-84A0F1A6F282 Q39587210-1CC4E886-1178-4572-A2AD-2DD7B55D9E49 Q39651295-F58A8574-5B33-4524-8941-430B0E966017 Q41120997-09DE53A5-F83A-41D9-976D-62D8261B31B7 Q42483685-C81835E6-516D-485C-AB1D-4F7C5ED20A15 Q47961085-DCE46622-FCA6-42B4-85E4-401E4CF8BC40 Q51749781-87971A61-E7B5-46DF-99EC-474CE43B2520 Q54997136-EFDC7661-DE8E-42E9-8F16-D55C35BD5C84 Q55020898-33592B71-A90C-42FF-ACA0-D086D6997D2D

P2860

Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.

http://www.wikidata.org/entity/Q35860804

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Galanin receptor subtype 2 sup ...... nt head and neck cancer cells.

@ast

Galanin receptor subtype 2 sup ...... nt head and neck cancer cells.

@en

type

label

Galanin receptor subtype 2 sup ...... nt head and neck cancer cells.

@ast

Galanin receptor subtype 2 sup ...... nt head and neck cancer cells.

@en

prefLabel

Galanin receptor subtype 2 sup ...... nt head and neck cancer cells.

@ast

Galanin receptor subtype 2 sup ...... nt head and neck cancer cells.

@en

P1433

Q35860804-54C6DD8C-40D7-44CC-9609-587352F36428

P1476

Q35860804-F7910208-BA95-4092-A4A8-DE30FC95944E

P2093

Q35860804-0BDEB8E0-1CCF-4BC8-AB00-AFC5F65482C3

Q35860804-388E5644-F88A-47FC-A43E-33063B780A14

Q35860804-51C2AD63-F050-4955-A21F-693E27F00531

Q35860804-645C000A-BBC1-4E5E-B3B9-0AB6A3BD1516

Q35860804-7A1FCF8B-F345-4DFB-AD5B-AD92947AD53F

Q35860804-851DCE95-73CB-400F-8E11-04D0D4CD907A

Q35860804-B44665E7-7C6C-41D6-BDBE-DBE436491CA4

Q35860804-D30FE2B9-0AEC-42AB-B04E-6D27636826FE

Q35860804-FF8D6898-508F-4E50-9657-F208C828021F

P2860

Q35860804-08B5B877-A5E3-49B0-9CD6-AAB1EEA2A231

Q35860804-16C3DF54-75B0-431D-9DD8-312A3BE200F1

Q35860804-1C977B27-1528-4EE9-B162-875E94D5D58D

Q35860804-24D5F10E-C80E-4CCD-9534-78276385C61B

Q35860804-2B21CBB3-2B22-4CE5-A52B-3447C036AF47

Q35860804-2EFC5D6E-8DC3-4AD3-912E-7A0D6A550D5A

Q35860804-331F9227-30F5-4107-975E-F423CDD37B46

Q35860804-421D31ED-FF6D-4230-A042-15414F0F74CC

Q35860804-4DA3A4F9-78B2-4F22-934C-92FC805AF047

Q35860804-4E68A4F1-A2AD-44AE-A832-4F51D7C7F720

P304

Q35860804-EECE5F65-36CC-41C9-B63C-5AE5DFAD656D

P31

Q35860804-3CEA351C-44D9-460F-8CD4-42DCE462BCB3

P356

Q35860804-2515FC3C-D502-4545-ABAF-2C0878CC7D43

P407

Q35860804-160F53C8-2199-460B-B2DC-92BA65D22825

P433

Q35860804-269CCDED-A93A-43DE-B8FC-4A9C7662EAF7

P478

Q35860804-C2B61D00-E4BD-49EF-AB8D-24BBA036BFC4

P50

Q35860804-B89757C6-4929-4DB8-AC37-A6843380D290

P577

Q35860804-12CA6829-4674-414A-8052-723A963E1526

P5875

Q35860804-74C12300-EA86-4149-B384-07981BA36086

P698

Q35860804-81DD836F-B1EA-427A-93C0-646F6A6792C5

P932

Q35860804-EEB2B360-EABA-4553-B46D-AF93B11360CE

P356

1078-0432.CCR-08-2443

P1433

Clinical Cancer Research

P1476

Galanin receptor subtype 2 sup ...... ant head and neck cancer cells

@en

P2093

Bhavna Kumar

http://www.w3.org/2001/XMLSchema#string

Ilwhan Jang

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Misawa

http://www.w3.org/2001/XMLSchema#string

Pavan K Kommareddi

http://www.w3.org/2001/XMLSchema#string

Takeharu Kanazawa

http://www.w3.org/2001/XMLSchema#string

Thankam S Nair

http://www.w3.org/2001/XMLSchema#string

Toshihide Iwashita

http://www.w3.org/2001/XMLSchema#string

Yuki Misawa

http://www.w3.org/2001/XMLSchema#string

Yukiko Iino

http://www.w3.org/2001/XMLSchema#string

P2860

SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis

Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer

Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells

Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2

The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors

G-protein-coupled receptors: past, present and future.

Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).

Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238.

p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

P304

2222-2230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-08-2443

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Thomas E. Carey

P577

2009-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24191413

http://www.w3.org/2001/XMLSchema#string

P698

19276245

http://www.w3.org/2001/XMLSchema#string

P932

3315370

http://www.w3.org/2001/XMLSchema#string